Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Type

Journal article

Journal

The Lancet Oncology

Publisher

Elsevier

Publication Date

01/04/2020

Addresses

SP Blagden, University of Oxford, Department of Oncology, Oxford, United Kingdom, AD Cook, MRC Clinical Trials Unit, Institute of Clinical Trials and Methodology, London, United Kingdom, C Poole, University Hospital Coventry, Oncology, Coventry, United Kingdom, L Howells, Maggie Keswick Jencks Cancer Caring CentresTrust (Maggie’s), London, United Kingdom, IA McNeish, Imperial College London, Department of Surgery and Cancer, London, United Kingdom, A Dean, St John of God Subiaco Hospital, Oncology, Subiaco, Australia, JW Kim, Seoul National University Hospital, Obstetrics and Gynaecology, Seoul, South Korea, DM O’Donnell, Cancer Trials Ireland, Gynaecology Subgroup, Dublin, Ireland, J Hook, St. James’s University Hospital, Leeds, United Kingdom, R Lord, Clatterbridge Cancer Centre, Department of Oncology, Wirrall, United Kingdom, G Dark, Newcastle University, Department of Oncology, Newcastle upon Tyne, United Kingdom, HM Earl, Addenbrooke's Hospital, Department of Medical Oncology, Cambridge, United Kingdom, M Hall, Mount Vernon Cancer Centre, Northwood, United Kingdom, R Kaplan, MRC Clinical Trials Unit, Institute of Clinical Trials and Methodology, London, United Kingdom, JA Ledermann, University College London, Cancer Research UK & University College London Cancer Trials Centre, London, United Kingdom, AR Clamp, The Christie NHS Foundation Trust and University of Manchester, Manchester, United Kingdom